PHARMCO II ApS: Financial statements 2016
CVR: 25202899
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -20,625 and a net result of DKK 2,271,044 compared with DKK 2,968,899 the year before. Equity in the 2016 report amounted to DKK 56,698,908. The solvency ratio was 99.2%.
- Gross Profit
- DKK -20,625
- Profit/Loss
- DKK 2,271,044
- Equity
- DKK 56,698,908
- Total Assets
- DKK 57,137,741
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -21 t. | 2.3 mio. | 56.7 mio. | - |
| 2015 | - | 17.8 mio. | 3 mio. | - | 37 |
| 2014 | - | -21 t. | 1.8 mio. | 52.8 mio. | 34 |
| 2013 | - | -19 t. | 3.6 mio. | 51.1 mio. | - |
| 2012 | - | -19 t. | 3.6 mio. | 47.7 mio. | - |
Official annual report
Find more companies like PHARMCO II ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PHARMCO II ApS has published its annual report for 2015. Gross profit came to DKK 17,759,834, and the net result was DKK 2,968,899.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.